Introduction {#sec1}
============

Neuroendocrine tumors (NETs) were initially described by Oberndofer using karzinoid (carcinoid) in 1907 and mostly arise from the neuroendocrine cells with the ability to generate hormonal-related peptides \[[@B1],[@B2]\]. Small intestinal neuroendocrine tumors (SI-NETs), the most common subset in gastrointestinal neuroendocrine tumors, are featured by aggressiveness and therapy-resistance \[[@B1],[@B3]\]. During the last three decades, the incidence of SI-NETs has annually increased by 3.8% \[[@B4]\]. In fact, the age-adjusted incidence of NETs (over 30 years old) in digestive system has dramatically increased by 720%, with 225% increasing in ileal part and 460% in small intestinal \[[@B4]\]. However, the five-year survival rate surprisingly remains unchanged \[[@B4]\].

Of note, SI-NET patients commonly are diagnosed as advanced stage at initial presentation due to indolent unnoticeable clinical course \[[@B1]\]. Numerous terms have been associated with the prognosis of SI-NET, including age, carcinoid heart diseases, lymph node metastases, liver tumor load, peritoneal carcinomatosis, and tumor cell proliferation (WHO grade) \[[@B2],[@B5],[@B6]\]. Moreover, the somatostatin analogs treatment has significantly improved the tumor progression in well-differentiated metastatic midgut NETs \[[@B7]\].

Despite the fact that therapeutic progressions have been made, the overall clinical benefits of SI-NETs remain far from satisfactory. Reasonably, simplified therapeutic management of SI-NETs does not fully capture the full biological picture. In fact, molecular characterization of SI-NETs would contribute to the development of novel therapeutic strategies. Interestingly, frameshift mutation of CDKN1B (encoding p27) was found in 7.8% SI-NETs patients, indicating the role of cell cycle dysregulation involved \[[@B8]\]. In addition, nine miRNAs were found differentially expressed during tumor progression (miR-96, -182, -183, 196a, -200a, -31, -129-5p, -133a, and -215) \[[@B9]\]. Moreover, a subset of SI-NETs clustered by transcriptome files was characterized by longer survival and higher expression of SSTR2, whereas shorter survival was associated with higher grade or gain of chromosome 14 \[[@B5]\]. However, the molecular picture of SI-NETs remains largely unclear.

In the present study, the gene expression profile GSE65286, deposited by Andersson co-workers, was analyzed using bioinformatics strategy \[[@B5]\], followed by functional enrichment analysis of differentially expressed genes (DEGs) and the identification of key genes and pathways.

Materials and methods {#sec2}
=====================

Gene expression profile {#sec2-1}
-----------------------

The gene expression profile GSE65286, containing 10 primary tumors (T), 10 normal small intestine mucosa (N), 2 lymph nodes metastases (LN), 21 tumor with liver metastases samples (LM), was retrieved from the Gene Expression Omnibus (GEO) (<http://www.ncbi.nlm.nih.gov/geo/>) \[[@B5],[@B10]\]. All the RNA was retrieved from the fresh-frozen samples using the miRNeasy Mini Kit (Qiagen) and synthesized and labeled following the One-Color Microarray-Based Gene Expression Analysis protocol (v5.7). Next, the Whole Human Genome Microarrays (GPL4133, G4112F, ID: 014850, Agilent Technologies) were used for hybridization. The scanning process was performed using Agilent Microarray Scanner G2565BA (Agilent Technologies) and the results were processed by Feature extraction version 10.7.1.1 (Agilent Technologies) with normalization \[[@B5]\].

Identification of DEGs and functional enrichment {#sec2-2}
------------------------------------------------

Identification of DEGs was performed by the GEO2R analytical tool \[[@B11]\]. The cut-off values of DEGs were defined by the adj. *P*-value\<0.05 (Benjamini and Hochberg's False discovery rate, FDR,) and \|log2 fold change (logFC)\|\>2. The Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene ontologies (GO), including biological processes (BP), cellular components (CC) and molecular functions (MF), were annotated by R package ClusterProfiler and the Database for Annotation, Visualization and Integrated Discovery (DAVID) \[[@B12]\].

Gene set enrichment analysis {#sec2-3}
----------------------------

The gene set enrichment analysis (GSEA) was performed using the Broad Institute GSEA software (<http://software.broadinstitute.org/gsea/index.jsp>) \[[@B15]\] with the annotation file "hallmark gene sets" and default cutoff values (*P*-value\<0.05).

Construction of protein--protein interaction networks {#sec2-4}
-----------------------------------------------------

The protein--protein interaction (PPI) networks were established by the DEGs interactions generated by the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING <http://www.string-db.org/>). The minimum required interaction score was set as medium confidence (0.400). Active interaction sources included textmining, experiments, databases, co-expression, neighborhood, gene fusion and co-occurrence. The results were visualized via the Cytoscape software (version 3.6.0) \[[@B16],[@B17]\]. Hub genes were defined by the top 10 genes with highest degree values. The Molecular Complex Detection (MCODE) was used to subset the PPI networks \[[@B18]\].

Artificial neural networks for hub gene network models {#sec2-5}
------------------------------------------------------

Artificial neural networks (ANNs) are characterized by non-linear mathematical models with highly parameterized input for the description of complex systems \[[@B19]\]. Unlike conventional linear regression models, ANNs are featured by "black boxes" powerful algorithms \[[@B21]\]. In fact, ANNs generate challenging networks that could approximate outcomes with minimal errors, however, with abstract interpretations \[[@B19]\]. In the present study, ANNs were used to predict the metastasis status of SI-NETs with the input (I1--I5) of previously identified hub genes (ALB, FGG, AHSG, TF, and GC) and the output was the metastasis status (O1, 0 = non metastasis, 1 = metastasis). The hidden process in the complex mathematical models was illustrated by H1--H5 (the number of hidden units is selected based on the best calculated accuracy). All the hidden nodes further led to the output (O1). All the bias factors were represented by bias nodes (B1, B2) similar to the intercept term in a linear model. All the relative importance of hub genes and the metastasis were identified using the Garson's algorithm in the NeuralNetTool package (version 1.5.1) in R software \[[@B22]\].

Results {#sec3}
=======

Identification of DEGs {#sec3-1}
----------------------

Given GSE65286 only contained 2 LN samples, the comparison only performed in N (*n* = 10) versus T (*n* = 10) and T (*n* = 10) versus LM (*n* = 21). A total of 613 DEGs were identified between N and T, with 301 down-regulated and 312 up-regulated. Sixty-one DEGs were identified between T and LM, with 44 down-regulated and 17 up-regulated ([Figure 1](#F1){ref-type="fig"}A--D).

![Identification of DEGs in primary tumors (T) versus normal (N) group, as well as T versus liver metastases (LM) group\
(**A**) The heat map of DEGs in T versus N group; (**B**) the heat map of DEGs in T versus LM group; (**C**) the volcano plot of DEGs in T versus N group; (**D**) the volcano plot of DEGs in T versus LM group.](bsr-40-bsr20193860-g1){#F1}

GO and KEGG enrichments {#sec3-2}
-----------------------

For DEGs between N and T, digestion (*P*-value = 8.09E−13), apical plasma membrane (*P*-value = 3.11E−07), and metal ion transmembrane transporter activity (*P*-value = 3.00E−05) were the top significantly enriched terms in BP, CC, and MF, respectively ([Figure 2](#F2){ref-type="fig"}A). In terms of pathway, fat digestion and absorption, protein digestion and absorption as well as maturity onset diabetes of the young were the top enriched pathways in KEGG ([Figure 2](#F2){ref-type="fig"}B). For DEGs between T and LM, antimicrobial humoral response (*P*-value = 5.41E−05), blood microparticle (*P*-value = 1.75E−12), and BMP binding (*P*-value = 0.000501) were the top significantly enriched terms in BP, CC, and MF, respectively ([Figure 2](#F2){ref-type="fig"}C). However, the complement and coagulation cascades was the only significantly enriched KEGG pathway between T and LM ([Figure 2](#F2){ref-type="fig"}D).

![GO and KEGG results of DEGs in T versus N and T versus LM groups\
(**A**) GO enrichments of DEGs in T versus N group; (**B**) KEGG pathways of DEGs in T versus N group; (**C**) GO enrichments of DEGs in T versus LM group; (**D**) KEGG pathways of DEGs in T versus LM group.](bsr-40-bsr20193860-g2){#F2}

GSEA {#sec3-3}
----

In GSEA, there were five gene sets significantly enriched in the tumor group and one gene set in the liver metastasis group, whereas no significantly enriched gene set between normal and tumor groups. In the liver metastasis group, only spermatogenesis was significantly enriched (*P*-value = 0.018, enrichment score (ES) = −0.39). In the tumor group, the five gene sets included Notch signaling (*P*-value\<0.001, ES = 0.61), inflammatory response (*P*-value\<0.001, ES = 0.58), coagulation (*P*-value = 0.035, ES = 0.57), KRAS signaling (*P*-value = 0.04, ES = 0.46), and allograft rejection (*P*-value = 0.041, ES = 60) ([Figure 3](#F3){ref-type="fig"}).

![GSEA of primary tumors (T) versus liver metastases (LM) groups\
(**A**--**E**) Significantly enriched pathways in T group; (**F**) significantly enriched pathway in LM group.](bsr-40-bsr20193860-g3){#F3}

PPI networks construction {#sec3-4}
-------------------------

The PPI networks in T versus N group (PPI-TvsN) contained 395 nodes with 1046 edges whereas the PPI networks constructed in T versus LM (PPI-TvsLM) contained 36 nodes with 76 edges ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). Top three subsets were identified by MCODE in Both PPI networks with significantly enriched pathways ([Table 1](#T1){ref-type="table"}). The hub genes in the PPI-TvsN included coagulation factor II, thrombin (F2), glucagon (GCG), neurotensin (NTS), cystic fibrosis transmembrane conductance regulator (CFTR) and apolipoprotein B (APOB) ([Table 2](#T2){ref-type="table"}). The hub genes in the PPI-TvsLM included albumin (ALB), fibrinogen gamma chain (FGG), alpha 2-HS glycoprotein (AHSG), transferrin (TF), and GC, vitamin D binding protein (GC) ([Table 2](#T2){ref-type="table"}).

![PPI networks of DEGs in T versus N group\
The degree of each node was reflected by the color and the size. The higher the degree, the darker and bigger the node is.](bsr-40-bsr20193860-g4){#F4}

![PPI networks of DEGs in T versus LM group\
The degree of each node was reflected by the color and the size.](bsr-40-bsr20193860-g5){#F5}

###### The MCODE with significantly enriched pathways

               Cluster ID   Nodes   Edges   Node IDs                                                                                                                                                                                             KEGG pathways                                            *P*-value
  ------------ ------------ ------- ------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------- -----------
  PPI TvsN     1            11      55      P2RY2, OXTR, EDN2, LPAR5, NTS, TAC1, CCK, GCG, EDN3, CASR, F2                                                                                                                                        hsa04080: neuroactive ligand--receptor interaction       0.009186
               2            28      84      APOA4, MGST1, XPNPEP2, GSTA1, APOC2, ABCG5, CYP2S1, ACE2, MME, MEP1A, MEP1B, ADCY2, SHBG, DPP4, GSTA5, GSTA2, FABP2, CYP2B6, MTTP, CYP2C18, APOC3, CXCL13, CCL25, OPRK1, APOB, APOA1, SSTR2, GSTA3   hsa00980: metabolism of xenobiotics by cytochrome P450   1.90E−07
                                                                                                                                                                                                                                                 hsa04975: fat digestion and absorption                   2.20E−07
                                                                                                                                                                                                                                                 hsa00982: drug metabolism -- cytochrome P450             3.71E−06
                                                                                                                                                                                                                                                 hsa05204: chemical carcinogenesis                        8.30E−06
                                                                                                                                                                                                                                                 hsa04974: protein digestion and absorption               1.33E−05
                                                                                                                                                                                                                                                 hsa00480: glutathione metabolism                         3.02E--05
                                                                                                                                                                                                                                                 hsa04977: vitamin digestion and absorption               0.002802
                                                                                                                                                                                                                                                 hsa00830: retinol metabolism                             0.022278
                                                                                                                                                                                                                                                 hsa03320: PPAR signaling pathway                         0.024271
               3            5       9       MUC17, GALNT6, MUC13, MUC2, GALNT7                                                                                                                                                                   hsa00512: mucin type O-glycan biosynthesis               0.008993
  PPI T vsLM   1            9       32      APOA2, FGG, HP, AHSG, ALB, HRG, TF, GC, RBP4                                                                                                                                                         --                                                       --
               2            3       3       MUC17, DEFA5, DEFA6                                                                                                                                                                                  --                                                       --
               3            3       3       RSPO1, RSPO2, RSPO3                                                                                                                                                                                  --                                                       --

The MCODE was an embedded algorithm in the Cytoscape software (version 3.6.0); T: tumor; N: normal; LM: liver metastases. Node IDs: represent each gene symbol.

###### Hub genes in PPI networks of tumor versus normal groups and tumor versus liver metastases groups

                    Gene symbol   Gene name                                             Degree
  ----------------- ------------- ----------------------------------------------------- --------
  PPI T versus N    F2            Coagulation factor II, thrombin                       42
                    GCG           Glucagon                                              36
                    NTS           Neurotensin                                           32
                    CFTR          Cystic fibrosis transmembrane conductance regulator   30
                    APOB          Apolipoprotein B                                      27
  PPI T versus LM   ALB           Albumin                                               21
                    FGG           Fibrinogen gamma chain                                11
                    AHSG          Alpha 2-HS glycoprotein                               11
                    TF            Transferrin                                           10
                    GC            GC, vitamin D binding protein                         10

T: tumor; N: normal; LM: liver metastases; degree: represents the connection between each two genes.

Correlations of hub genes {#sec3-5}
-------------------------

Next, the pairwise correlation of hub genes in both PPI networks was analyzed respectively in each phenotype ([Figure 6](#F6){ref-type="fig"}A--D). Remarkably, the highest correlation observed between GCG and NTS (cor = 0.86) in N group was altered in T group, with the correlation between NTS and APOB as the highest one (cor = 0.87). Meanwhile, the correlation of CFTR and APOB, as well as CFTR and GCG, CFTR and NTS were increased distinctly ([Figure 6](#F6){ref-type="fig"}A,B). Noteworthy, the correlation of hub genes between T and LM displayed a dramatic positive change ([Figure 6](#F6){ref-type="fig"}C,D). In fact, given the distinct correlational alterations of hub genes between T and LM groups, these hub genes were chosen for further ANN analysis.

![Hub gene correlations\
(**A,B**) The pairwise correlations of hub genes identified by DEGs in T versus N groups; (**C,D**) the pairwise correlations of hub genes identified by DEGs in T versus LM groups.](bsr-40-bsr20193860-g6){#F6}

ANN for hub genes models {#sec3-6}
------------------------

Increasingly values of AI have been recognized in association with prediction models and data interpretation. Therefore, ANN analysis was introduced to build a model of hub genes using Garson's algorithm. Specifically, the weights of hub genes in this model are more analogous to the coefficients of linear model, given the fact that large number of adjustable weights could lead to nonlinear effects with challenging interpretation. The relative importance of each node was represented by the combined effects of weight. In fact, the relative importance of each hub gene was determined by dissecting the model weights and reflected by a value ranging from 0 to 1 via the R package, NeuralNetTool. Of note, ALB and TF were the most important predictors of metastasis ([Figure 7](#F7){ref-type="fig"}A). Next, the hub genes were input for the construction of neural network ([Figure 7](#F7){ref-type="fig"}B). In this network, five neurons were identified in hidden layer. The output layer, O1, referred to tumor status (primary or metastasis). Black lines showed positive weighted connections while grey showed negative connections. Bias terms were displayed using an independent neuros, B1 and B2, serving as the intercept of a linear model. Moreover, to visualize the correlation between categorized features and all cases, a facetted heat map was illustrated for the feature weights between primary tumor and metastasis groups. Intriguingly, the expression of ALB≤7.44 showed the highest support to the primary tumor whereas 10.64\<ALB≤15.97 and ALB\>15.97 both supports the metastasis ([Figure 7](#F7){ref-type="fig"}C). Meanwhile, TF≤7.54 showed the highest negative correlation to the primary tumor ([Figure 7](#F7){ref-type="fig"}C). In addition, FGG≤2.32 supports the primary tumor whereas 6.42\<FGG≤11.36 and FGG\>11.36 showed supports for metastasis ([Figure 7](#F7){ref-type="fig"}C).

![ANN models for hub genes in T versus LM groups\
(**A**) Relative importance of hub genes to metastasis status; (**B**) ANN interpretation diagram of hub genes to metastasis outcome; positive correlation was indicated by black while negative correlation was indicated by grey lines with the relative significance of each weight in proportion to the line thickness; (**C**) heat map of categorized expression of hub genes in association with all selected patients. The patients number were shown at the horizontal line whereas the categorized feature at the left vertical line (gene expression); the positive feature weight was marked by green and the negative by red.](bsr-40-bsr20193860-g7){#F7}

Discussion {#sec4}
==========

The present study identified potential pathways and genes associated with the tumorigenesis and metastasis in SI-NETs by re-analyzing the gene expression profile of GSE65286. Compared with the original study by Andersson et al. \[[@B5]\], the present study focused on the DEGs in tumor process with multiple bioinformatics strategies, including GSEA and ANN. Intriguingly, Notch signaling (*P*-value\<0.001, ES = 0.61) was the top enriched gene sets in T compared with N group. Commonly, Notch1 signaling is absent from NETs and its significant tumor suppressor role has been confirmed \[[@B23]\]. In fact, Notch signaling pathway has been identified as a key regulator for the neuroendocrine differentiation in gastrointestinal carcinoid tumors by inducing the Notch effector hairy and enhancer of split 1 (Hes1) and reducing the achaete--scute complex homolog-like 1 (Asc11/hASH1) \[[@B24]\]. Furthermore, overexpression of Notch signaling also significantly reduced serotonin concentration and corresponding serotonin-reactive cells as well as the expression of tryptophan hydroxylase 1 \[[@B24]\].

Noteworthy, the hub genes from the DEGs between N and T groups (F2, GCG, NTS, CFTR, and APOB) displayed marked correlational alterations ([Figure 6](#F6){ref-type="fig"}A,B), which further highlighted the potential mechanistic insights. In fact, CFTR has been involved in the modulation of neurosecretory activity of the pulmonary neuroendocrine cell and neuroepithelial bodies O~2~ sensor functions \[[@B25]\]. The role of CFTR in SI-NETs remains to be disclosed. Interestingly, our study indicated that the correlations of CFTR with the other four hub genes were markedly increased in T compare to N group ([Figure 6](#F6){ref-type="fig"}A,B). Reasonably presume that the aberration of CFTR could be key in the tumorigenesis of SI-NETs via the simultaneous interaction with F2, GCG, NTS, and APOB.

Meanwhile, the hub genes from the DEGs between T and LM groups (ALB, FGG, AHSG, TF, and GC) also showed marked alterations in the correlations, indicating potential mechanisms involved in the tumor metastasis. Given the close correlations in-between the hub genes (ALB, FGG, AHSG, TF, and GC), the present study further employed non-linear mathematical models to delineate the network with ANN algorithms. In fact, the implications of ANN strategy in genetic mechanism remain sparse due to the challenging interpretations and fundamental difference between conventional explanatory models. Nonetheless, ANN is featured by approximating outcomes using powerful description of complex system with minimal errors \[[@B19]\]. In fact, the heat map of categorized features facilitates the ANN-based prediction makings. The ANN network models can be insightful evidences for the ultimate decision process. However, given the complex fitting algorithms in ANN-based prediction models, potential over-fitting was not discussed in the present study.

Limitations of the present study included the quality of normal control samples. In fact, the normal intestinal mucosal samples were retrieved from the resected samples of 10 colorectal cancer patients \[[@B5]\]. Of note, Andersson et al. also proposed that normal intestinal mucosal may not be the optimal control for primary tumors in SINET due to lack of sufficient endocrine cell \[[@B5]\]. Moreover, the lack of experimental mechanistic validation for hub gene correlations and ANN analysis also limited the power of the results.

Conclusion {#sec5}
==========

This bioinformatics analysis provided insights on potential key pathways and genes networks involved in SI-NETs and established an ANN-based hub gene model for metastatic prediction.

Special thanks to Dr. Erik Kristiansson (A professor in Biostatistics, Applied Mathematics and Statistics, Department of Mathematical Sciences, Chalmers University of Technology/University of Gothenburg, Sweden) for his contribution and assistance in data explanation.

Competing Interests {#sec6}
===================

The authors declare that there are no competing interests associated with the manuscript.

Funding {#sec7}
=======

The authors declare that there are no sources of funding to be acknowledged.

Author Contribution {#sec8}
===================

CY and QW carried out experiments and data analysis, drafted the manuscript, and participated in study design and data collection. Both the authors read and approved the final manuscript.

ANNs

:   artificial neural networks

BP

:   biological processes

CC

:   cellular components

DAVID

:   Database for Annotation, Visualization and Integrated Discovery

DEGs

:   differentially expressed genes

GEO

:   Gene Expression Omnibus

GO

:   gene ontologies

GSEA

:   gene set enrichment analysis

KEGG

:   Kyoto Encyclopedia of Genes and Genomes

MCODE

:   Molecular Complex Detection

MF

:   molecular functions

NET

:   neuroendocrine tumor

PPI

:   Protein--protein interaction

SI-NET

:   small intestinal neuroendocrine tumor
